Embol, officially known as Embol S.A., is a leading player in the biotechnology industry, headquartered in Bolivia (BO). Founded in 2005, the company has established itself as a pioneer in the development of innovative medical solutions, particularly in the fields of vascular and interventional therapies. With a strong operational presence across South America, Embol focuses on producing high-quality embolic agents and medical devices that cater to the needs of healthcare professionals. Their unique offerings, such as advanced embolisation products, are designed to enhance patient outcomes and streamline clinical procedures. Recognised for its commitment to research and development, Embol has achieved significant milestones, positioning itself as a trusted name in the medical sector. The company continues to expand its market reach, driven by a dedication to innovation and excellence in patient care.
How does Embol's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Embol's score of 5 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Embol (Embotelladoras Bolivianas Unidas S.A.) reported significant carbon emissions, totalling approximately 62,441,068,000 kg CO2e for Scope 1, 59,160,965,232,000 kg CO2e for Scope 2, and 947,000 kg CO2e for Scope 3 emissions. This data highlights the company's substantial carbon footprint across its operations. Embol has committed to achieving net-zero emissions by 2050, with a long-term target that encompasses all scopes of emissions. This commitment aligns with the Science Based Targets initiative (SBTi) framework, which the company has engaged with since November 2021. The company aims to implement strategies that will significantly reduce its carbon emissions over the coming decades. Overall, Embol's climate commitments reflect a proactive approach to addressing climate change, with a clear focus on reducing emissions across all operational scopes.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2020 | 2021 | |
---|---|---|---|
Scope 1 | 52,260,638,000 | 00,000,000,000 | 00,000,000,000 |
Scope 2 | 76,290,719,392,000.02 | 00,000,000,000,000.00 | 00,000,000,000,000.00 |
Scope 3 | 1,460,000 | 0,000,000 | 000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Embol is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.